Bruxism Treatment Market, by Disease Type (Primary bruxism, Secondary bruxism), by Treatment Type (Therapeutics(Muscle Relaxants, Botox Injection, Anti-anxiety drugs), Devices (Mouth Guards, NTI-tss and Splints)), by Patient Type (Children, Adults) , by

Bruxism Treatment Market, by Disease Type (Primary bruxism, Secondary bruxism), by Treatment Type (Therapeutics(Muscle Relaxants, Botox Injection, Anti-anxiety drugs), Devices (Mouth Guards, NTI-tss and Splints)), by Patient Type (Children, Adults) , by End User (Hospitals, Dental Clinics, Homecare Settings, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

The term ‘bruxism’ refers to excessive jaw clenching or teeth grinding. Both adults and children can be afflicted by this condition, which can happen at day or night. Some individuals show no symptoms. Others may encounter dental issues, tooth discomfort, jaw pain, or headaches. Kids with this illness frequently get better on their own. Adults who wear dental guards may benefit from tooth damage protection.

Market Dynamics

Increase in partnerships, collaborations and agreements between market players is expected to boost the global bruxism treatment market growth over the forecast period. For instance, in September 2019, GuardLab Inc., a U. S. basedin the sports technology industry that uses 3D scanning and 3D printing to produce the mouthguards in the market, announced a partnership with Bauer Hockey, manufacturer of hockey equipment, to supply a new line of Bauer APEX and APEX Lite Mouthguards, a GuardLab product.

Increasing number of product approvals and launches are expected to bolster growth of the global bruxism treatment market. For instance, in November 2021, The U.S. Food and Drug Administration (FDA) granted SprintRay Inc. approval to market its NightGuard Flex 3D printing resin as a Class II medical device in the U.S. SprintRay Inc. is a company involved in digital dentistry and 3D printing solutions. The SprintRay NightGuard Flex joins SprintRay's leading lineup of end-to-end dental 3D printing solutions and is intended for the production of orthodontic and dental appliances such as mouthguards, nightguards, and splints.

Increasing research and development activities regarding bruxism are expected to drive growth of market over the forecast period. For instance, according to an article published in Journal of Dentistry and Oral Sciences in May 2022, occlusal splint is used to prevent damage from symptoms of bruxism. An occlusal splint is recommended as the first line of protection against noise bruxism and tooth wear in patients suffering from sleep bruxism. The use of an occlusal splint improves patient comfort by lowering muscular activity. It indicates that using an occlusal splint lessens orofacial pain, masticatory muscle tension, and teeth grinding.

Key features of the study:

• This report provides an in-depth analysis of global bruxism treatment market, market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains an attractive investment proposition matrix for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global bruxism treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include Bravrr, Brux Night Guard, Leiner Health Products Inc., Pfizer, Eli Lilly , Patterson Dental Supply Inc., Carestream Dental LLC., Randmark Dental Products LLC, Allergan Aesthetics, S4S (UK) Limited, Viatris Inc., and SprintRay Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make an informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics.
• The Global Bruxism Treatment Market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global bruxism treatment market.

Detailed Segmentation:

• Global Bruxism Treatment Market, By Disease Type:
• Primary Bruxism
• Secondary Bruxism
• Global Bruxism Treatment Market, By Treatment Type:
• Therapeutics
• Muscle relaxants (Acetaminophen, etc.)
• Botox injections
• Anti-anxiety drugs (Fluoxetine, Sertraline, etc.)
• Devices
• Mouth Guards
• NTI-tss and splints
• Global Bruxism Treatment Market, By Patient Type:
• Children
• Adult
• Global Bruxism Treatment Market, By End User:
• Hospitals
• Dental Clinics
• Homecare Settings
• Others (Research Centers, Academic Institutes, etc.)
• Global Bruxism Treatment Market, By Region:
• North America
• By Country:
• U.S.
• Canada
• Latin America
• By Country:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country:
• U.K.
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country:
• GCC
• Israel
• Rest of Middle East
• Africa
• By Country/Region:
• South Africa
• Central Africa
• North Africa
• Company Profiles
• Bravrr *
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Brux Night Guard,
• Leiner Health Products Inc.,
• Pfizer
• Eli Lilly
• Patterson Dental Supply Inc.
• Carestream Dental LLC.
• Randmark Dental Products LLC
• Allergan Aesthetics
• S4S (UK) Limited
• Viatris Inc.
• SprintRay Inc.

“*” marked represents similar segmentation in other categories in the respective section.